Harrington, J., Sun, J., Fonarow, G. C., Heitner, S. B., Divanji, P., Alhanti, B., … Greene, S. (2023). APPLICABILITY OF THE GALACTIC-HF TRIAL AND OMECAMTIV MECARBIL TO PATIENTS HOSPITALIZED FOR HEART FAILURE IN THE UNITED STATES: FROM THE GWTG-HF REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 81, pp. 473–473).

Harrington, Josephine, Jie Sun, Gregg C. Fonarow, Stephen B. Heitner, Punag Divanji, Brooke Alhanti, Larry A. Allen, et al. “APPLICABILITY OF THE GALACTIC-HF TRIAL AND OMECAMTIV MECARBIL TO PATIENTS HOSPITALIZED FOR HEART FAILURE IN THE UNITED STATES: FROM THE GWTG-HF REGISTRY.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 81:473–473, 2023.

Harrington J, Sun J, Fonarow GC, Heitner SB, Divanji P, Alhanti B, et al. APPLICABILITY OF THE GALACTIC-HF TRIAL AND OMECAMTIV MECARBIL TO PATIENTS HOSPITALIZED FOR HEART FAILURE IN THE UNITED STATES: FROM THE GWTG-HF REGISTRY. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2023. p. 473–473.

Harrington, Josephine, et al. “APPLICABILITY OF THE GALACTIC-HF TRIAL AND OMECAMTIV MECARBIL TO PATIENTS HOSPITALIZED FOR HEART FAILURE IN THE UNITED STATES: FROM THE GWTG-HF REGISTRY.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 81, no. 8, 2023, pp. 473–473.

Harrington J, Sun J, Fonarow GC, Heitner SB, Divanji P, Alhanti B, Allen LA, Yancy CW, Albert NM, DeVore A, Felker GM, Greene S. APPLICABILITY OF THE GALACTIC-HF TRIAL AND OMECAMTIV MECARBIL TO PATIENTS HOSPITALIZED FOR HEART FAILURE IN THE UNITED STATES: FROM THE GWTG-HF REGISTRY. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2023. p. 473–473.